American Conference Institute (ACI) will be holding its 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements from November 12-14, 2008 in New York. The conference will allow attendees to:
• Leverage intellectual property and draft favorable exclusivity provisions;
• Anticipate the potential impact of M&A activity on your transaction;
• Negotiate co-development rights;
• Protect rights relating to future developments and improvements;
• Evaluate viable compensation structures;
• Minimize risks through partner selection and due diligence;
• Ensure effective alliance management;
• Negotiate hotly contested issues with universities; and
• Avoid the top pitfalls of international deals.
In particular, ACI's faculty will offer presentations on the following topics on November 12 and 13:
• Factoring takeaways from recent deals and trends into your collaborations strategy;
• Limiting the potential for litigation: Best drafting practices after Quanta and MedImmune;
• Prelude to acquisition? Incorporating M&A considerations into your collaboration strategy;
• Leveraging intellectual property: Negotiating exclusivity, co-promotes and other critical terms to accelerate development and maximize profits;
• Incorporating international business strategies into collaborative agreements;
• Successfully negotiating collaborative research agreements with academic institutions;
• Alliance management: Establishing governance structures for successful collaborations;
• Asset spin-outs: Overcoming challenges in negotiating out licensing by pharma and big biotech;
• Setting the stage for success by choosing the right partner and conducting effective due diligence; and
• Defining critical termination rights.
Two additional master classes entitled: "Sustaining a Successful Collaboration Through Effective Alliance Management" and "The 'Win-Win' Collaborative Agreement: Practical and Ethical Negotiating and Drafting Strategies" will be offered on November 13 and 14, respectively. In the first master class, experts in making collaborations work will show you how to ensure that the alliance's objectives are met. The second master class will walk attendees through the key aspects of negotiating and drafting that are essential to successful agreements.
The agenda for the Pharma/Biotech Collaborative Agreements conference can be found here. A complete brochure for this conference, including an agenda, list of speakers, and registration form can be downloaded here.
The registration fee ranges from $2,195 (conference alone) to $2,795 (conference and one master class) to $3,395 (conference and two master classes). Those registering on or before September 8, 2008 will receive a $300 discount off the registration fee and those registering on or before October 20, 2008 will receive a $200 discount off the registration fee. Those interested in registering for the conference can do so here, by calling 1-888-224-2480, or by faxing a registration form to 1-877-927-1563.
Comments